MolAgent
Pre-seed · Building Early Access →
An AI research agent for materials

MolAgent
Accelerating materials innovation with AI.

MolAgent is an AI research agent for materials science. It brings the newest scientific methods into working use, conducts complete simulation studies, and returns results you can trust.

An expert across every level of theory
methods.proposed · curated_pipelines
Quantum
DFT · ab initio · TD-DFT
Atomistic
classical MD · force fields
Coarse-Grained
MARTINI · DPD · mesoscale
E = f(graph)
ML-Accelerated
MACE · NequIP · Allegro
$ molagent
The Agent
proposes · runs · analyzes
Every scale has its own codes, its own formats and its own traps — and a real project combines several of them. MolAgent is fluent across every level of theory. It doesn't decide for you: it proposes strategies, explains the trade-offs, and once you have chosen, it sets up the calculation, launches it, monitors progress and interprets the output.
describe · launch · arbitrate
4 levels
Theory levels covered
12 mo → 1 wk
Expert study, reproduced
100% on-prem
Runs on your hardware
0 outbound
Your data never leaves
01 / the bottleneck

Simulation is powerful and expensive to run properly.

The cost is not the computing. It is the expert knowledge required at three separate stages: setting the calculation up, executing it, and validating that the answer means anything. Each stage can silently invalidate everything after it, and only a handful of people in any laboratory can carry all three.

01
Setup is where studies quietly go wrong
Every code has its own input syntax, conventions and silent traps. A minor error in a configuration produces an incorrect result, a wasted allocation, or a failure discovered three weeks later. The cost is paid twice: in compute and in the time spent finding out.
Costly
02
Execution takes weeks before anything is usable
Preparation, equilibration, monitoring, restart, analysis. Weeks pass before the first result worth looking at, and the person doing it is usually the one you least want doing it.
Slow
03
Validation is skipped because it is expensive
Convergence, reference comparison, uncertainty. Everyone knows it should be done. Under deadline it gets shortened, and results get used anyway.
Risky
04
A few people carry all of it
Two or three people per laboratory can run these workflows end to end. Everything queues behind them, and when they leave, the protocols leave too.
Structural
02 / why now

AI opens a new era but not on its own.

For the first time, a scientist can describe an objective instead of writing input files. That is genuinely new. It is also not sufficient, and pretending otherwise is how a plausible answer becomes a wasted quarter of compute.

What AI makes possible
Interaction in plain language
Describe a scientific objective without having mastered every tool it depends on.
Technical work, automated
Generate the code, prepare the files, chain the steps together without manual bookkeeping.
A scientist who is assisted
Explain, guide, analyse, and help interpret what the numbers actually mean.
Where generic AI hits its limit
Broad knowledge, not expertise
Answers can be entirely plausible and still be scientifically wrong — the most expensive failure mode there is.
Results that aren't deterministic
The same request can lead to different methodological choices on different days. Science needs the opposite.
Workflows that are too complex
A real simulation demands a long chain of validations and expert decisions, not a single clever answer.
AI alone is not enough. It has to be framed by scientific workflows that are reliable, reproducible, and validated by experts.
03 / the approach

The reasoning of an AI, on methods built by experts.

MolAgent is not a chatbot that talks about chemistry. It runs the same simulation codes your group already runs, through methods a computational chemist designed, and it checks its own work along the way.

01 · AI reasoning
You describe, it plans
Understands the objective, decides on an approach, sequences the steps, explains what it is doing and why. You talk to it in ordinary language and it asks you when a decision is yours to make.
02 · Expert methods
Validated, structured, reproducible
The workflows are built and verified by computational chemists, grounded in the accepted practice of the field. The same request produces the same methodological choices, which is what makes a result defensible.
03 · Complete execution
Setup, execution and validation
All three stages, not just the middle one. It prepares, runs, monitors, evaluates its own results, and runs additional checks or calculations when it judges them necessary. You approve, adjust, or send it back. The agent installs alongside the simulation software you already run, so your structures and results stay inside your organisation.
01
Understands
Interprets the objective and identifies a suitable strategy, stating what would count as a usable result.
02
Prepares and runs
Configures the workflow, generates the inputs, and launches the calculations on your systems.
03
Monitors and checks
Watches execution, detects errors and instabilities, adapts the steps, and evaluates whether the result holds.
04
Analyses and proposes
Puts the results in context, concludes, states what remains uncertain, and proposes the next step.
For the expert Weeks of repetitive technical work delegated, and the studies you designed but never had time to run.
For the team without a specialist Simulation becomes usable, at a standard someone else can check.
HOW IT FITS
molagent · v0.1.0
YOU
Researcher
  • State the objective
  • Review the proposed approach
  • Approve, adjust, decide
  • Own the conclusion
MOLAGENT
MolAgent CLI
  • Expert-built method library
  • Study design and setup
  • Input and job generation
  • Execution, monitoring, adaptation
  • Validation and reporting
  • Memory of your systems and conventions
YOUR ENVIRONMENT
HPC · Workstation · Cloud
  • Your existing computing resources
  • Your installed simulation software
  • Your storage and your results
01
Setup & Job Generation
Validated inputs for LAMMPS, VASP, GROMACS, CP2K, ORCA and others, calibrated to your system and your group's conventions. Submission, monitoring, restart and scaling on your queues.
02
Study Design
Breaks an objective into a plan: what to compute, at what level of theory, in what order, at what cost. Presents the alternatives and the trade-offs.
03
Validation
Convergence testing, comparison against reference data, uncertainty, and a record of every decision taken. The agent evaluates its own results and runs further checks when it judges them necessary.
04
Potentials Specialised to Your Chemistry
Machine-learned interatomic potentials fine-tuned on your own system, with active learning and uncertainty quantification. Three orders of magnitude faster than the reference calculation, at an accuracy you can defend.
05
Screening & Exploration
Large sets of candidates with active selection of what to compute next. Structure prediction, polymorph ranking, miscibility, adsorption, barriers, transport.
06
Analysis & Interpretation
Structural, dynamic and electronic properties, mapped onto quantities an experimentalist measures. Figures, and an explanation of what they mean.
07
Laboratory Memory
Protocols, past results, what failed and why. Last year's study becomes an asset for this year's.
08
Inside Your Organisation
Installs where the work already happens. Nothing is uploaded.
04 / methods

Four scales, one search space.

Real studies move between levels of description: survey cheaply, look closer where the answer is uncertain, confirm at the highest accuracy the budget allows. Each level has its own codes, formats and silent traps, and a real project combines several.

01 · Electrons
Quantum
Describes electrons explicitly to predict structure, energy and reactivity. Reactions, electronic properties, small molecules.
VASP Quantum ESPRESSO CP2K ORCA PySCF
02 · Atoms
Molecular Dynamics
Follows the motion of atoms over time. Structure, diffusion, interactions, complex systems. Enhanced sampling and free-energy landscapes.
LAMMPS GROMACS NAMD OpenMM PLUMED
Q P N C C C C
03 · Groups of atoms
Coarse-Grained
Groups atoms together to reach larger scales. Membranes, large assemblies, self-assembly, soft matter.
MARTINI DPD ESPResSo HOOMD-blue VOTCA
E-equivariant message passing
04 · AI + physics
Learned Potentials
Near-quantum accuracy at the speed of molecular dynamics, specialised to your chemistry with active learning and uncertainty quantification. Large-scale screening, long dynamics, complex systems.
MACE NequIP Allegro UMA GAP
candidate → score → select
05 · Composition & structure
Screening Pipelines
Automated exploration of composition and structure with active selection of the next calculation.
Materials Project OQMD AFLOW AiiDA Atomate
r (Å) g(r)
06 · Observables
Analysis & Validation
Properties mapped to measurable quantities, convergence and uncertainty reported with every number, reproducible notebooks and publication-ready figures.
MDAnalysis ASE pymatgen OVITO VMD
05 / roadmap

From working agents to a delivered product.

A working prototype is used by two scientists today, with five more ready for the beta.

Progress
Phase 3 of 6
Updated Q3 2026 · Next review Q1 2027
2025
Complete
Foundation
Company incorporated. Architecture defined. First methods designed.
H1 2026
Complete
Working agents
Agents running real studies end to end. Prototype with two scientists.
H2 2026
In progress
Alpha and pilots
Deployable version installed with partners. Two to three pilots. Five scientists ready for the beta.
4
H1 2027
Planned
First product
Deliverable product. First results published with a pilot partner.
5
H2 2027
Planned
Launch
General availability on annual licence. Seed round.
6
2028 →
Vision
Extension
Pharmaceutical, biomedical and energy. European and US expansion.
06 / markets

Where MolAgent creates value today.

Three customer archetypes with the same underlying pain and three different procurement paths, inside a market growing at roughly 12% a year and backed by major public investment in AI-for-science.

$4.4B
Computational chemistry
market in 2034
≈ 12%
Annual growth
over the period
Up from roughly $1.7B in 2026. Public momentum is building on top of it: over $5B committed to the US Genesis Mission across ~300 projects, €107M for Europe's RAISE pilot with materials science as a flagship area, and €2.5B for AI under France 2030.
Source: Fortune Business Insights
01
Universities & research groups
The need: accelerate projects, standardise methods, reduce dependence on two or three people. The value: the execution is automated and the group's practice is captured instead of walking out the door.
Computational chemistry Materials science Biomolecular labs
02
Computing centres & national laboratories
The need: open complex infrastructure to a wider set of users without multiplying human support. The value: more science per machine-hour, and a documented, auditable practice available to every user.
EuroHPC facilities Government labs AI factories
03
Industrial R&D
The need: accelerate discovery in-house, with confidential data and reliability requirements. The value: complete studies run inside the perimeter, with the validation attached so a decision can be taken on the result.
Pharma & biotech Energy Semiconductors
07 / team

Two complementary profiles.

Not an outsider's guess at what scientists need. The science comes from someone who has spent a career doing it by hand; the engineering from someone who has shipped AI systems at scale.

Shamil Saiev
Shamil Saiev
Founder & Chief Scientist
  • Research professor, PhD in computational chemistry
  • More than a decade in molecular simulation, from quantum to coarse-grained
  • Peer-reviewed scientific publications
  • Author of multiple reference workflows in the field
→ The scientific expertise that defines the method.
linkedin.com/in/shamil-saiev-94b148161
Aslan Vatsaev
Aslan Vatsaev
Co-founder & AI Engineering
  • Generative AI engineer at Edenred, previously at Doctolib
  • Has built AI systems at large scale
  • Specialist in AI that runs locally, without the cloud
  • Former R&D engineer at IRCAD, Strasbourg
→ The engineering that makes the product possible.
linkedin.com/in/avatsaev
Early access · Pilots · Collaborations

The study you designed and never had the months to run.

We are opening early access to a small group of research teams, computing centres and industrial R&D groups. Two scientists use the prototype today and five more are ready for the beta.

Stage
Pre-seed